BMRN

BioMarin Pharmaceutical
D

BMRN

57.670
USD
-0.99
(-1.69%)
مغلق
حجم التداول
41,852
الربح لكل سهم
4
العائد الربحي
-
P/E
17
حجم السوق
11,073,482,040
أصول ذات صلة
ALNY
ALNY
-1.65
(-0.36%)
452.39 USD
EXEL
EXEL
-0.600
(-1.56%)
37.910 USD
GILD
GILD
-1.355
(-1.19%)
112.555 USD
INCY
INCY
-1.140
(-1.34%)
83.710 USD
I
IONS
-0.120
(-0.28%)
42.630 USD
NBIX
NBIX
0.710
(0.51%)
138.950 USD
REGN
REGN
-7.33
(-1.25%)
579.13 USD
R
RGEN
3.250
(2.73%)
122.190 USD
S
SRPT
0.250
(1.38%)
18.335 USD
المزيد
الأخبار المقالات

العنوان: BioMarin Pharmaceutical

القطاع: Healthcare
الصناعة: Biotechnology
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline oftreatments in development.